Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide does cause nausea for many people, particularly in the first few weeks, but the idea that it makes everyone seriously unwell is a misconception worth unpicking. Most side effects are gastrointestinal, mild to moderate in intensity, and tend to settle as the body adjusts. They are a known part of how the medicine works, not a sign that something is going wrong. That said, semaglutide is a Prescription-Only Medicine and a prescriber will assess your individual health picture before it is ever dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A significant number of people searching this question are already on semaglutide and wondering whether the nausea they feel means they should stop. The answer, in most cases, is no. Feeling queasy at the start of treatment or after a dose step-up is so well documented in clinical trials that researchers built the slow titration schedule precisely to reduce it. The starting dose exists to let your digestive system adapt, not to produce results straight away.
In the STEP 1 trial, published in the New England Journal of Medicine, nausea was the most frequently reported adverse event among participants taking semaglutide 2.4mg, yet the majority continued treatment and the rates of discontinuation due to side effects were relatively low. That context matters. Feeling rough for a fortnight is genuinely unpleasant, but it is a different thing from a serious adverse reaction.
If you are struggling and want to understand why semaglutide causes sickness in some people more than others, the mechanism has a straightforward explanation: GLP-1 receptor agonists slow how quickly food leaves the stomach. When the stomach stays fuller for longer, appetite drops, but early in treatment that same effect can produce nausea, bloating, or an unsettled feeling after eating. It tends to improve once the body has recalibrated.
The typical side-effect profile of semaglutide is led by the gut. Nausea, loose stools or constipation, indigestion, burping, and abdominal discomfort are all commonly reported. Fatigue, headache, and dizziness appear less frequently. The NHS medicines page for semaglutide lists these clearly alongside practical advice for managing them, eating smaller portions, avoiding rich or fatty foods, and drinking plenty of water are consistently helpful.
There is, though, a smaller category of symptoms that should prompt a call to a prescriber or, in some situations, a visit to urgent care. In January 2026 the MHRA updated its guidance to flag acute pancreatitis as a known but infrequent risk with GLP-1 medicines: if you experience severe, persistent stomach pain that spreads towards your back, with or without vomiting, you should seek medical help promptly rather than waiting. Gallbladder problems, signs of a serious allergic reaction, and symptoms of significant dehydration after prolonged vomiting or diarrhoea also fall into this category. Suspected reactions can be reported at the MHRA Yellow Card scheme.
For the large majority of people, though, the experience of semaglutide making them feel sick is temporary, and you can find detailed guidance on what to do when semaglutide makes you feel unwell if you want to know how to respond in the moment. It peaks around dose increases and gradually recedes.
If you are a few weeks in and finding the nausea difficult, you are not alone. A lot of people feel caught between relief that the medicine is suppressing their appetite and frustration that mealtimes have become uncomfortable. That is a completely reasonable place to be, and it is worth knowing there are practical steps before simply pushing through.
Eating slowly, choosing bland low-fat foods during the first week of any new dose, and stopping when you feel full rather than finishing your plate all reduce the severity of GI symptoms. Cold or room-temperature drinks tend to be better tolerated than hot ones. Timing the injection for an evening dose so that the peak effect occurs overnight can help some people, though any changes to timing should be discussed with your prescriber first. For a fuller breakdown, the team at our clinical team reviews this regularly with patients who contact aftercare.
One thing worth understanding is that dose increases are the highest-risk moments for nausea to return. The slower the titration, the lower the peak discomfort. If the current dose feels manageable, there is no obligation to rush to the next level. That decision belongs to your prescriber, who will look at both tolerability and progress before advising a change.
You can read more about the full side-effect profile of Wegovy if you want a broader picture of what to expect across the treatment course. And if cost or access is a consideration alongside tolerability, the Wegovy cost page sets out what private treatment typically involves.
Contact your prescriber if side effects are stopping you eating or drinking adequately, if they have not improved at all after two or three weeks on a stable dose, or if you experience anything from the urgent-symptoms list above. Do not wait until your next scheduled review if symptoms are severe. Many services, including nume, offer aftercare seven days a week specifically for this kind of question.
Suitability for semaglutide is assessed before a prescription is written, not after. A GPhC-registered Independent Prescriber reviews your health history, current medicines, and BMI to identify anything that might increase your risk of side effects or make the medicine unsuitable. People with a personal or close family history of medullary thyroid carcinoma or multiple endocrine neoplasia, a history of pancreatitis, or certain gastrointestinal conditions will typically not be prescribed it. Being in good general health reduces, but does not eliminate, the chance of GI symptoms in the early weeks.
If you are considering starting and want to understand whether semaglutide might suit you, a free consultation through our treatment page is reviewed the same day by a prescriber. There is no commitment. And if you would prefer to read more about the wider weight-loss treatment options available first, that is a sensible place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.